# About Kisspeptin Chemical: An Independent Research Digest

> About Kisspeptin Chemical — an independent editorial project publishing plain-English, cited summaries of the peer-reviewed Kisspeptin literature. Not a clinic, not a vendor.

An independent editorial digest of the published Kisspeptin literature — read discovery-first, sourced, and plain.

## What this site is

Kisspeptin Chemical is an independent editorial project that publishes summaries of the peer-reviewed research literature on Kisspeptin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "chemical" in the name is editorial framing — a position this publisher occupies relative to the literature, reading kisspeptin as a research compound traced from gene to hormone. It is not a claim that the site offers any chemical, product, consultation, or service.

## How we read the literature

This digest takes a discovery-first view: kisspeptin's story runs from a 1996 cancer-suppressor gene, through the deorphanization of GPR54, to the 2003 finding that recast it as the master switch of the reproductive axis. We lead with what each study measured and attribute it to its source. Doses appear only as what was administered to a stated population by a stated route — never as guidance. Every quantitative claim is cited to a PubMed-indexed study on the [references](/references) page.

## What we are careful about

Kisspeptin is investigational: no regulator has approved any kisspeptin product for any indication, and it is not a dietary supplement. We say so on every page. We keep kisspeptin in its correct place — upstream of GnRH, not itself a sex hormone or a GnRH-agonist drug — and we flag its defining limitation, tachyphylaxis, wherever dosing schedule or efficacy is discussed. Subjective community reports about sexual desire, fertility, or testosterone are kept clearly separate from cited findings and labeled as anecdotal, not clinical evidence. We use generic compound names only.

## Who writes this

Kisspeptin Chemical is an editorial publication, not a person or a practice. It carries no named clinician, no physical clinic, and no consultation service. It exists to make a dense, technical literature readable and verifiable for curious readers — to summarize the science accurately, cite it, and leave the practice of medicine to physicians.

---

A discovery-first reading of the Kisspeptin record — the KISS1 gene traced from metastasis suppressor to the master switch above GnRH, every human finding logged to its source and the not-approved, not-a-supplement status held in plain sight; no clinic behind the cascade, and nothing here dosed, dispensed, or sold.